RVPs are most commonly used in neutralization assays, which measure the ability of serum or antibodies to prevent<unk>  infectivity in vitro, with applications in vaccine development, antibody discovery, and serological testing. A related assay tests for antibody-dependent enhancement (ADE), a phenomenon where non-neutralizing antibodies against<unk> es can increase infectivity through their binding to the cellular Fc receptor, aiding entry of the<unk>  into host cells. An RVP neutralization assay. COVID-19 patient sera and a monoclonal antibody neutralize the infectivity of SARS-CoV-2 RVPs in a concentration-dependent fashion.
Reporter virus particles
Genetically modified virus
Genetically modified bacteria
Microbial cell factory
Virus counter
Virulence factor
Bacterial adhesin
Tax gene product